Detalles de la búsqueda
1.
The beneficial impact of metabolic dysfunction-associated fatty liver disease on lenvatinib treatment in patients with non-viral hepatocellular carcinoma.
Hepatol Res
; 53(2): 104-115, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36149726
2.
Platinum sensitivity in patients with IDH1/2 mutated vs wild-type intrahepatic cholangiocarcinoma: A propensity score-based study.
Int J Cancer
; 151(8): 1310-1320, 2022 10 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35723131
3.
Validation of the easy-to-use lenvatinib prognostic index to predict prognosis in advanced hepatocellular carcinoma patients treated with lenvatinib.
Hepatol Res
; 52(12): 1050-1059, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-35960789
4.
Role of circulating microRNAs to predict hepatocellular carcinoma recurrence in patients treated with radiofrequency ablation or surgery.
HPB (Oxford)
; 24(2): 244-254, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34366240
5.
Adverse events as potential predictive factors of activity in patients with advanced hepatocellular carcinoma treated with lenvatinib.
Liver Int
; 41(12): 2997-3008, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34250737
6.
Role of the prognostic nutritional index in predicting survival in advanced hepatocellular carcinoma treated with regorafenib.
Hepatol Res
; 51(7): 796-802, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-34005839
7.
Lenvatinib versus Sorafenib as first-line treatment in hepatocellular carcinoma: A multi-institutional matched case-control study.
Hepatol Res
; 51(12): 1229-1241, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34591334
8.
Germline testing and genetic counseling in biliary tract cancer: an operative proposal to improve the state of art.
Expert Rev Gastroenterol Hepatol
; 18(4-5): 141-146, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38584510
9.
Five years of lenvatinib in hepatocellular carcinoma: are there any predictive and/or prognostic factors?
Expert Rev Anticancer Ther
; 23(1): 19-27, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36472371
10.
Past, present, and future of FGFR inhibitors in cholangiocarcinoma: from biological mechanisms to clinical applications.
Expert Rev Clin Pharmacol
; 16(7): 631-642, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37387533
11.
Retrospective Evaluation and Significance of Neutrophil-to-Lymphocyte Ratio Prior to and 1 month Following Microwave Ablation of Hepatocellular Carcinoma.
Cardiovasc Intervent Radiol
; 46(1): 49-59, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36180599
12.
Updated survival outcomes with ivosidenib in patients with previously treated IDH1-mutated intrahepatic-cholangiocarcinoma: an Italian real-world experience.
Ther Adv Med Oncol
; 15: 17588359231171574, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37457302
13.
Clinical Outcomes After Progression on First-Line Therapies in IDH1 Mutated Versus Wild-Type Intrahepatic Cholangiocarcinoma Patients.
Target Oncol
; 18(1): 139-145, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36689074
14.
Why does survival of hepatocellular carcinoma patients remain so low? Key stumbling blocks and questions in preclinical and clinical development.
Expert Opin Investig Drugs
; 31(5): 483-494, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35275784
15.
Real-World Data on Ivosidenib in Patients with Previously Treated Isocitrate Dehydrogenase 1-Mutated Intrahepatic Cholangiocarcinomas: An Early Exploratory Analysis.
Target Oncol
; 17(5): 591-596, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36114954
16.
Real Life Study of Lenvatinib Therapy for Hepatocellular Carcinoma: RELEVANT Study.
Liver Cancer
; 11(6): 527-539, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36589723
17.
Molecular profile and its clinical impact of IDH1 mutated versus IDH1 wild type intrahepatic cholangiocarcinoma.
Sci Rep
; 12(1): 18775, 2022 11 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36335135
18.
A Novel Prognostic Tool in Western and Eastern Biliary Tract Cancer Patients Treated in First-line Setting: the ECSIPOT Index.
J Gastrointest Cancer
; 53(3): 528-536, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34033000
19.
Risk-adjusted analysis of survival variability among hospitals treating biliary malignancy.
J Chemother
; 34(8): 543-549, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-35156913
20.
Gene mutational profile of BRCAness and clinical implication in predicting response to platinum-based chemotherapy in patients with intrahepatic cholangiocarcinoma.
Eur J Cancer
; 171: 232-241, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35749808